BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $280,000 | -4.4% | 3,479 | 0.0% | 0.04% | -10.4% |
| Q1 2021 | $293,000 | +2.1% | 3,479 | -2.7% | 0.05% | 0.0% |
| Q4 2020 | $287,000 | -2.7% | 3,575 | -2.6% | 0.05% | -15.8% |
| Q3 2020 | $295,000 | -11.4% | 3,671 | -5.2% | 0.06% | -16.2% |
| Q2 2020 | $333,000 | -2.3% | 3,871 | -7.8% | 0.07% | -19.0% |
| Q1 2020 | $341,000 | -5.5% | 4,198 | -2.7% | 0.08% | +18.3% |
| Q4 2019 | $361,000 | -18.3% | 4,315 | -14.6% | 0.07% | -24.5% |
| Q3 2019 | $442,000 | +4.7% | 5,052 | -2.0% | 0.09% | -2.1% |
| Q2 2019 | $422,000 | -4.5% | 5,153 | -5.3% | 0.10% | -5.0% |
| Q1 2019 | $442,000 | +23.5% | 5,442 | 0.0% | 0.10% | +7.4% |
| Q4 2018 | $358,000 | -21.7% | 5,442 | -8.1% | 0.09% | -9.6% |
| Q3 2018 | $457,000 | -11.4% | 5,924 | -15.2% | 0.10% | -16.1% |
| Q2 2018 | $516,000 | +10.5% | 6,984 | -2.8% | 0.12% | +14.8% |
| Q1 2018 | $467,000 | -2.1% | 7,184 | -2.7% | 0.11% | 0.0% |
| Q4 2017 | $477,000 | +0.2% | 7,380 | -2.8% | 0.11% | -5.3% |
| Q3 2017 | $476,000 | +2.8% | 7,590 | -0.7% | 0.11% | -3.4% |
| Q2 2017 | $463,000 | +34.6% | 7,640 | +15.1% | 0.12% | +34.1% |
| Q1 2017 | $344,000 | +60.7% | 6,640 | +37.4% | 0.09% | +49.2% |
| Q4 2016 | $214,000 | -97.5% | 4,833 | -95.9% | 0.06% | -97.8% |
| Q3 2016 | $8,422,000 | +2886.5% | 116,480 | +1768.5% | 2.71% | +3209.8% |
| Q2 2016 | $282,000 | -19.4% | 6,234 | -26.9% | 0.08% | -26.1% |
| Q1 2016 | $350,000 | -10.0% | 8,525 | -16.4% | 0.11% | -19.0% |
| Q4 2015 | $389,000 | -9.7% | 10,200 | -22.3% | 0.14% | -11.6% |
| Q3 2015 | $431,000 | -90.5% | 13,125 | -79.7% | 0.16% | -89.7% |
| Q2 2015 | $4,514,000 | -29.4% | 64,550 | -30.9% | 1.50% | -29.8% |
| Q1 2015 | $6,398,000 | -28.5% | 93,395 | -23.6% | 2.14% | -28.0% |
| Q4 2014 | $8,954,000 | +1.7% | 122,175 | -0.4% | 2.98% | +2.9% |
| Q3 2014 | $8,801,000 | +4.5% | 122,625 | +5.3% | 2.89% | +6.6% |
| Q2 2014 | $8,422,000 | -1.6% | 116,480 | +0.1% | 2.71% | -9.1% |
| Q1 2014 | $8,560,000 | – | 116,330 | – | 2.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |